ArticlePharmacoEconomics2014
Cost-effectiveness analysis of docetaxel versus weekly paclitaxel in adjuvant treatment of regional breast cancer in New Zealand.
Rachel Webber-Foster et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this paperpooled itcites it